具体来说，购买定制款CGM的用户，可免费预约京东护士到家提供专业佩戴指导，服务覆盖47个核心 城市，最快1小时上门响应。依托京东互联网医院的三甲医生资源，用户还能在线获取个性化控糖方 案，结合营养师定制的饮食运动建议，形成"监测-分析-干预-跟踪"的一站式服务体系。 此外，供应链的高效协同是"双十一"保障消费体验的关键。京东健康与鱼跃医疗提前数月启动备战"双 十一"，基于历史销售数据、市场趋势与营销计划进行智能预测，将商品前置到全国核心仓储节点。借 助京东覆盖全国的物流网络与智能分仓能力，鱼跃制氧机、血压计、CGM等爆款产品实现绝大部分地 区当日或次日达。 值得一提的是，鱼跃全球产业化基地生产的产品，通过地下无人物流通道直达智能仓库，再由京东物流 快速配送至消费者手中，全链路高效流转，既保障了发货时效，也确保了产品运输安全。 "京东健康平台用户对品质和专业性的要求非常高，这与鱼跃的品牌理念高度契合。"于才皓表示，鱼跃 在京东平台推出的多款监测类产品，既是企业洞察市场后自主研发的成果，也借助平台的流量与服务能 力更快地被用户了解和接受。未来，公司希望与京东健康一起，推动数字化健康管理设备向数字疗法方 向发展。 ...

Core Viewpoint - The collaboration between JD Health and Himalaya aims to enhance diabetes management through digital and intelligent health services, improving the quality of life for diabetes patients [1][4]. Group 1: Diabetes Prevalence and Management Needs - As of 2024, the number of diabetes patients in China has reached 148 million, with projections suggesting it will approach 170 million by 2030 [3]. - Many diabetes patients are unaware of their condition, highlighting the need for increased awareness and early screening [3]. - Key preventive measures for workplace populations include weight control, maintaining a positive mindset, and regular exercise [3]. Group 2: Healthcare Services and Collaborations - JD Health has partnered with over 800 pharmaceutical companies focused on diabetes medication, providing comprehensive health services from medication to management [4]. - The JD Internet Hospital has seen a 40% year-on-year increase in consultations related to diabetes as of November 1 [4]. - JD Health and Sanofi have established the "Feifan Guardian - Diabetes Care Center" to offer online consultations, medication guidance, and nutritional advice [4]. Group 3: Future Directions - JD Health plans to continue enhancing chronic disease management services towards intelligent, personalized, and full-cycle approaches, contributing to the "Healthy China 2030" initiative [5].

Core Insights - The China Securities Regulatory Commission has officially accepted the filing for the overseas listing of QingSong Health Corporation, marking a significant step in the company's progress towards an IPO in Hong Kong [1] Company Overview - QingSong Health Corporation is a comprehensive health service enterprise focused on digital health management and insurance technology, offering services in health insurance, medical assistance, chronic disease management, and health service network construction [1] Listing Details - The company plans to issue no more than 36,496,400 ordinary shares on the main board of the Hong Kong Stock Exchange [1] - This filing indicates substantial progress in the company's journey towards public offering and listing [1]

Group 1 - The core point of the article is that QingSong Health Corporation has received formal acceptance of its overseas listing application from the China Securities Regulatory Commission, marking a significant step in its process to go public in Hong Kong [1] - QingSong Health Corporation plans to issue no more than 36,496,400 ordinary shares on the main board of the Hong Kong Stock Exchange [1] - The company focuses on digital health management and insurance technology, providing services in health insurance, medical assistance, chronic disease management, and health service network construction [1] Group 2 - The listing application signifies substantial progress in QingSong Health Corporation's efforts to establish a public offering and listing [1] - The company aims to offer convenient and affordable health protection and services to its users [1]

Core Insights - Alibaba Health and LEO Pharma have announced a strategic partnership focused on digital health management and innovative drug accessibility, aiming to enhance patient care and streamline health services [1] - The collaboration marks a significant milestone in the integration of internet platforms with the pharmaceutical industry, emphasizing patient-centered digital health management [1] - Both companies aim to leverage their strengths to improve the management of chronic skin diseases, providing personalized and efficient health management solutions [1] Company Collaboration - The partnership will explore scientific management of post-diagnosis home care scenarios, enhancing the treatment adherence and accessibility of innovative medications [1] - Alibaba Health's CEO highlighted the integration of LEO's innovative drugs with their digital capabilities to facilitate easier treatment adherence for patients [1] - LEO Pharma's executive emphasized the transformative impact of digital technology on healthcare, aiming to provide comprehensive support for patients with skin diseases [1] Project Outcomes - Previous collaborations have yielded significant results, with a notable 30% increase in medication adherence among patients involved in the skin disease management project [2] - Patients participating in chronic disease community management experienced a 3.2 times increase in medication adherence, leading to improved disease control [2] - These outcomes demonstrate the effectiveness of digital interventions in managing chronic skin diseases and provide valuable insights for the industry [2]

Core Viewpoint - Alibaba Health and LEO Pharma have announced a strategic partnership to enhance digital health management and improve accessibility to innovative treatments for skin diseases [1][4]. Group 1: Strategic Partnership - The collaboration focuses on technology-driven medical innovation, comprehensive health management, and improving the accessibility of innovative drugs [1]. - Alibaba Health has a user base of 300 million and has partnered with thousands of pharmaceutical companies globally [3]. - LEO Pharma has been active in China, promoting awareness and standardized treatment for skin diseases like psoriasis and atopic dermatitis, helping over 65 million patients [3]. Group 2: Digital Health Management - The partnership aims to deepen the patient-centered digital health management model, integrating LEO's innovative drugs with Alibaba's digital capabilities [4]. - Previous joint projects have shown significant results, with patient medication adherence increasing by 30% and up to 3.2 times for those in chronic disease community management [3]. - The collaboration will continue to explore scientific management in post-diagnosis home settings, providing smarter, personalized, and efficient health management solutions [5].

Core Viewpoint - Alibaba Health and LEO Pharma have announced a strategic partnership to enhance digital health management and improve accessibility to innovative medications for patients [1][2]. Group 1: Strategic Collaboration - The collaboration will focus on new technology-driven medical innovations, comprehensive health management, and improving the accessibility of innovative drugs [1]. - Alibaba Health has established partnerships with thousands of pharmaceutical companies globally, leveraging its digital capabilities and online channel advantages [1]. - LEO Pharma has been dedicated to promoting scientific understanding and standardized treatment awareness for skin diseases in China, helping over 65 million patients through various initiatives [1]. Group 2: Project Outcomes - Previous collaborations have led to significant results in skin disease management projects, enhancing patient adherence to medication and self-management of diseases [1]. - Data indicates that patient adherence to medication improved by 30% compared to the previous year, with a 3.2 times increase in adherence among patients participating in chronic disease community management [1]. Group 3: Future Directions - The partnership aims to further explore scientific management in post-diagnosis home settings, providing more intelligent, personalized, and efficient health management solutions for patients [2].

Core Insights - YanJia platform is a professional health service platform that provides comprehensive and personalized health management solutions, gaining significant attention through numerous successful cases [1][6] Group 1: Hair Loss Improvement - YanJia platform offers tailored health solutions for hair loss, exemplified by a user who experienced significant reduction in hair loss after using the recommended Brillowel hair growth tablets for two months [1] - The platform's health consultants, with an average service time exceeding 20,000 hours, create personalized health plans based on individual factors such as age and physical condition [1] Group 2: Children's Health Management - YanJia platform has shown notable results in children's health, where a parent sought help for their 4-year-old son suffering from poor sleep and appetite due to heat-related issues [3] - The platform's team of nutritionists and pediatric experts developed a personalized health plan focusing on a balanced diet and regular sleep patterns, leading to significant improvements in the child's sleep quality [3] Group 3: Weight Management - YanJia platform excels in weight management, assisting a busy professional who faced weight gain due to irregular eating and lack of exercise [4] - A comprehensive weight loss plan was created, emphasizing a reduction in high-calorie foods and the inclusion of fruits, vegetables, and exercise tailored to the individual's preferences, resulting in a weight loss of 5.5 pounds within ten days [4] Group 4: Future Directions - YanJia platform aims to continue its commitment to professional, attentive, convenient, and safe service, leveraging big data and artificial intelligence to explore new digital health management models [6] - The platform plans to strengthen collaborations with domestic and international professional institutions to provide more precise and comprehensive health management services [6]